YOLFTbeta
NanoRepro AG

NanoRepro AG

NN6 · XETRA · Healthcare / Diagnostics & Research

1.40EUR-0.04 (-2.44%)

Price History

Full chart

Market Stats

Previous Close1.44
Open1.45
Day Range1.35 – 1.45
52-Week Range1.31 – 2.40
Volume20.79K
Market Cap20.12M
P/E (TTM)0.00
Forward P/E86.96
EPS-0.14
Dividend Yield0.00%
Beta0.46
50-Day Avg1.82
200-Day Avg1.69

About

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMs. Lisa Jungst
  • Employees22
  • HeadquartersUntergasse 8, Marburg, Germany, 35037, Germany
  • Websitehttps://www.nanorepro.com

Leadership

  • Ms. Lisa JungstPresident of the Management Board & CEO
  • Mr. Stefan PiehChief Financial Officer

Financials

Income Statement

Currency: EUR2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue67.32K226.80K313.84K831.53K934.88K1.04M1.04M607.67K1.85M1.97M2.75M1.22M16.93M162.72M38.49M3.18M4.65M4.65M
Growth (%)-+236.89%+38.38%+164.95%+12.43%+11.43%+0.32%-41.85%+204.83%+6.45%+39.39%-55.67%+1289.58%+861.19%-76.35%-91.73%+45.99%+0.14%
Cost of Revenue61.16K110.36K111.68K349.55K405.03K71.36K158.00K266.79K1.05M868.52K1.14M949.33K12.27M108.98M28.59M1.35M1.70M1.64M
Gross Profit6.16K116.44K202.16K481.99K529.85K970.35K887.00K340.88K799.00K1.10M1.61M268.99K4.66M53.75M9.90M1.83M2.95M3.01M
Gross Margin9.15%51.34%64.42%57.96%56.68%93.15%84.88%56.10%43.13%55.96%58.50%22.08%27.52%33.03%25.73%57.47%63.38%64.69%
Operating Expense793.83K556.77K795.07K2.28M1.12M1.47M911.00K1.52M1.90M1.83M1.93M1.45M1.86M14.94M14.44M7.17M6.57M1.77M
Operating Income-787.67K-440.33K-592.91K-1.79M-587.01K-496.63K-24.00K-1.18M-1.10M-723.58K-323.45K-1.18M2.80M38.81M-4.53M-5.34M-3.62M1.24M
Operating Margin-1170.02%-194.15%-188.92%-215.70%-62.79%-47.67%-2.30%-193.45%-59.62%-36.69%-11.77%-96.97%16.53%23.85%-11.78%-167.75%-77.97%26.64%
EBITDA-761.84K-414.15K-619.92K-1.75M-545.00K-454.00K65.00K-957.93K-895.54K-530.58K16.50K-869.21K4.67M38.82M-4.35M-4.66M-3.42M-2.39M
EBITDA Margin-1131.65%-182.60%-197.53%-210.57%-58.30%-43.58%6.22%-157.64%-48.35%-26.91%0.60%-71.35%27.56%23.86%-11.31%-146.51%-73.57%-51.38%
Net Income-788.29K-440.82K-648.05K-1.79M-589.48K-497.70K-27.00K-1.18M-551.67K-734.08K-289.62K-1.19M1.69M29.72M-3.72M-4.69M-2.05M-1.99M
Net Income Margin-1170.94%-194.37%-206.49%-215.79%-63.05%-47.78%-2.58%-193.50%-29.78%-37.23%-10.54%-97.56%10.01%18.27%-9.68%-147.17%-44.02%-42.70%
Interest Expense7.37K9.03K6.73K2.24K2.71K4.00K3.00K1.15K4.91K10.38K7.59K7.48K18.30K52.35K772.5105.01K105.01K-
Interest Expense % of Total Revenue10.95%3.98%2.15%0.27%0.29%0.38%0.29%0.19%0.27%0.53%0.28%0.61%0.11%0.03%0.00%3.30%2.26%-

Balance Sheet

Currency: EUR2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets434.09K449.94K1.94M998.11K1.06M1.79M2.17M2.44M3.51M4.20M5.81M4.80M11.17M79.15M49.48M41.46M39.03M36.83M
Total Liabilities195.80K246.49K373.59K139.97K198.42K140.74K265.00K164.62K478.78K373.31K188.12K374.21K3.18M21.54M2.04M1.08M884.03K678.46K
Total Equity238.29K203.44K1.57M858.14K862.16K1.64M1.91M2.27M3.03M3.82M5.62M4.43M7.99M57.61M47.43M40.38M38.14M36.15M
Cash171.26K191.70K912.19K228.92K58.88K502.72K120.00K230.51K530.12K528.05K1.77M737.15K1.16M28.02M31.26M16.60M9.10M7.76M
Total Debt187.68K202.19K82.02K53.75K76.06K28.39K120.92K13.45K155.97K135.87K238.47198.18K1.35M150.00K----
Net Debt16.42K10.48K-830.16K-175.17K17.18K-474.32K919-217.06K-374.15K-392.18K-1.77M-538.98K188.13K-27.87M-31.26M-16.60M-9.10M-7.76M

Cash Flow

Currency: EUR2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-783.00K-548.00K-934.60K-769.70K-1.14M-257.60K-612.40K-1.12M8.16M13.14M-10.26M9.86M-
Investing Cash Flow-7.00K-215.00K-390.00K-380.40K-350.10K-440.90K-618.10K-316.80K-1.40K-3.31M-2.03M-17.17M-
Financing Cash Flow1.28M287.00K1.44M1.45M1.49M1.94M198.00K1.87M18.69M-6.60M-2.37M-188.80K-
Capital Expenditure7.00K215.00K1.60K8003.80K441.30K618.00K5001.40K3.31M0402.60K0
Free Cash Flow-790.00K-763.00K-936.20K-770.50K-1.15M-257.60K-612.40K-1.12M8.16M9.84M-10.26M9.46M-
Dividends Paid---------6.45M1.93M--
FCF to OCF100.89%139.23%100.17%100.10%100.33%100.00%100.00%100.04%99.98%74.85%100.00%95.92%-
Dividend Paid to FCF---------65.58%-18.84%--

Key Statistics & Ratios

Market Cap20.12M
Enterprise Value13.33M
Trailing P/E0.00
Forward P/E86.96
PEG Ratio0.00
Price / Sales4.64
Price / Book0.55
EPS-0.14
Book Value2.87
Revenue (TTM)4.34M
Gross Profit (TTM)2.69M
EBITDA-2.05M
Profit Margin-45.83%
Operating Margin-60.04%
Return on Equity-5.35%
Return on Assets-3.42%
Shares Outstanding12.61M
Shares Float11.36M
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.15Jun 16, 2023
20221×
0.50May 2, 2022

Stock Splits

  • Dec 4, 20201504:1475
  • May 28, 20181340:1311
  • May 19, 20161515:1511
  • Mar 6, 2015589:569
  • Oct 8, 2013100:99
  • Dec 1, 20101278:1265